These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37273120)

  • 41. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
    Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT3-confusion-of-function: Beyond the loss and gain dualism.
    Lodi L; Faletti LE; Maccari ME; Consonni F; Groß M; Pagnini I; Ricci S; Heeg M; Simonini G; Azzari C; Ehl S
    J Allergy Clin Immunol; 2022 Nov; 150(5):1237-1241.e3. PubMed ID: 35750105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.
    Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M
    Front Immunol; 2022; 13():1057679. PubMed ID: 36703986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009-2018).
    Xiang Q; Zhang L; Liu X; Wang S; Wang T; Xiao M; Zhao X; Jiang L
    Scand J Immunol; 2020 Jun; 91(6):e12885. PubMed ID: 32248557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).
    Heimall J; Davis J; Shaw PA; Hsu AP; Gu W; Welch P; Holland SM; Freeman AF
    Clin Immunol; 2011 Apr; 139(1):75-84. PubMed ID: 21288777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.
    He J; Shi J; Xu X; Zhang W; Wang Y; Chen X; Du Y; Zhu N; Zhang J; Wang Q; Yang J
    J Biosci; 2012 Jun; 37(2):243-57. PubMed ID: 22581330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
    Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
    Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome.
    Mahdaviani SA; Ghadimi S; Fallahi M; Hashemi-Moghaddam SA; Chavoshzadeh Z; Puel A; Rezaei N; Rekabi M; Daneshmandi Z; Sheikhy K; Kakhki AD; Saghebi SR; Pejhan S; Jamee M
    BMC Surg; 2023 Sep; 23(1):289. PubMed ID: 37741967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STAT3 mutations in the hyper-IgE syndrome.
    Holland SM; DeLeo FR; Elloumi HZ; Hsu AP; Uzel G; Brodsky N; Freeman AF; Demidowich A; Davis J; Turner ML; Anderson VL; Darnell DN; Welch PA; Kuhns DB; Frucht DM; Malech HL; Gallin JI; Kobayashi SD; Whitney AR; Voyich JM; Musser JM; Woellner C; Schäffer AA; Puck JM; Grimbacher B
    N Engl J Med; 2007 Oct; 357(16):1608-19. PubMed ID: 17881745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
    Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
    Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
    Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
    Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
    Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
    J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
    J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Update on Syndromes with a Hyper-IgE Phenotype.
    Bergerson JRE; Freeman AF
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
    Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
    Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.
    Wu J; Hong L; Chen TX
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):51. PubMed ID: 30112673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
    Paulson ML; Freeman AF; Holland SM
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
    van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
    Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.